This study investigated the hypothesis that supplementation of methionine (Met) to broiler diets increases muscle growth due to regulation of molecular pathways related to protein synthesis and degradation depending on the Met source. Day-old male Cobb-500 broilers (n = 240) were phase-fed three different wheat-soya bean 
| INTRODUC TI ON
Supplementing the AA limiting for protein synthesis has long been known to increase weight gain and breast muscle mass (Esteve-Garcia & Llauradó, 1997) , although the molecular pathways were not known in detail. While amino acids serve as substrates for protein synthesis, they also act as nutrient signals and regulators to control protein metabolism, for example, by modulating the function of translation initiation and elongation factors (Kimball & Jefferson, 2006; Métayer et al., 2008) . For example, neutral aliphatic AA, including Met and the branched-chain AA (BCAA), has been reported to stimulate ribosomal protein S6 kinase (S6K1) (Fox, Kimball, Jefferson, & Lynch, 1998) , a downstream target of the mammalian target of rapamycin (mTOR) signalling pathway, which initiates protein synthesis (Vary & Lynch, 2007) . Although Leucine (Leu) is unique in its capacity to stimulate mTOR phosphorylation (Atherton, Smith, Etheridge, Rankin, & Rennie, 2010) , some other AA including Met have been shown to stimulate the mTOR signalling pathway albeit to a lower degree than Leu in rodent cells (Atherton et al., 2010; Fox et al., 1998) and in avian myoblasts (Métayer-Coustard et al., 2010) . For example, the kinase S6K1 was activated in quail myoblasts in response to both Met and Leu supplementation (Tesseraud, Bigot, & Taouis, 2003) and Met deprivation lowered its activity (Métayer-Coustard et al., 2010) . Met restriction, via reduced glutathione production, has also been shown to lower activation of protein kinase B/Akt via the IGF1-PI3K-Akt-mTOR pathway and to lower fasting serum insulin levels in mice (Lees et al., 2017) . Akt does not only positively regulate mTOR, but it also negatively regulates the forkhead box protein O1 (FOXO1) transcription factor, which induces protein degradation (Glass, 2010) . Correspondingly, feeding high-Met diets compared to low-Met diets has been shown to alter gene expression in breast muscle of chickens; it increased the expression of the insulin-like growth factor (IGF1) and mTOR, while it decreased the expression of FOXO1 and its downstream target FBXO32 (Wen, Wu, Chen, Wang, & Zhou, 2014b) . This FBXO32 gene encodes an E3 ligase known as atrogin-1, which is a key enzyme for protein degradation via the ubiquitin-proteasome pathway (UPP), (Lecker, Goldberg, & Mitch, 2006) . Besides the autophagy-lysosomal pathway, UPP is a major pathway of skeletal muscle proteolysis (Lecker et al., 2006; Pasiakos & Carbone, 2014) . On the molecular level, Met + Cys deprivation has also been reported to induce autophagy in human glioma cells (Liu et al., 2015) , while Met supplementation has been reported to inhibit autophagy in yeast (Sutter, Wu, Laxman, & Tu, 2013) . Theoretically, the general control non-derepressible 2 (GCN2)/eukaryotic translation initiation factor 2A (eIF2a)-pathway may also be affected by Met, as GCN2 is a nutrient sensor activated by AA deficiency (Battu, Minhas, Mishra, & Khan, 2017) . Furthermore, Met supplementation has been found to inhibit the myostatin-Smad2/3 pathway, which acts as a negative regulator of muscle growth (Schiaffino, Dyar, Ciciliot, Blaauw, & Sandri, 2013) , and to increase the expression of several myogenic genes in growing broilers (Wen, Chen, et al., 2014a) . Therefore, it can be expected that Met supplementation promotes anabolism and represses catabolic processes, thereby favouring muscle protein synthesis in growing animals.
Interestingly, however, different Met sources seem to affect mTOR signalling differently as investigated in avian myoblasts (Métayer-Coustard et al., 2010) and porcine mammary gland cells (Zhang, Wang, et al., 2018b) . While supplementation of DL-Met and L-Met stimulated mTOR signalling in myoblasts compared to
Met-deprived cells, that of D-Met and DL-2-hydroxy-(4-methylthio)
butanoic acid (DL-HMTBA) did not (Métayer-Coustard et al., 2010) .
It is also unclear if the Met-dependent stimulation of mTOR signalling is specific to cell type and differs for example, between myoblasts and myotubes (Métayer-Coustard et al., 2010) Therefore, the aim of the present study was to investigate the effects of supplementation of different Met sources to growing broiler diets on the molecular pathways which are involved in the regulation of protein synthesis and degradation. We hypothesized that the increase in muscle growth due to supplementation of Met as the limiting amino acid is accompanied by an activation of the IGF1-PI3K-Akt-mTOR pathway and inhibition of pathways related to protein degradation, and that the effect on those pathways does not differ among two commercially available Met sources, namely DL-Met and DL-HMTBA.
| MATERIAL S AND ME THODS

| Birds and feeding
For this study, muscle samples from a recently performed experiment with broilers were used, which has been described earlier in detail (Zeitz et al., 2018) . In brief, 240-day-old male broiler chickens (Cobb 500, Cobb, Wiedemar, Germany) with an initial body weight of 40.1 ± 4.10 g (mean ± SD) were allotted to five experimental groups, 6 cages per group and 8 birds per cage. The broilers had free access to feed and water throughout the experiment and were phase-fed three different basal diets during days 1-10, 11-21 and 22-35 to meet or exceed their requirements for maintenance and growth according to the breeder's recommendations (www.cobb-vantress. com), except for Met + Cys which were approximately 25% below the breeder's recommendations and 15% below NRC (National Research Council (NRC) 1994) recommendations. The composition of the basal diets fed during the starter, grower and finisher phase is shown in Table 1 . The broilers were fed either the basal diets (Metgroup) or diets which were supplemented with 0.10% or 0.40% of Met either as DLM or DL-HMTBA. In favour of homogeneity of the diet, the liquid DL-HMTBA was supplemented as part of a product/ carrier (Sipernat) mix containing 58.6% DL-HMTBA. Therefore, to achieve an equimolar comparison, the DL-HMTBA was supplemented with 0.19% or 0.78% in the diet which additionally considered that DL-HMTBA content in the liquid product is 88%, thus that total DL-HMTBA content in the product was 51.6%. The diets supplemented with 0.10% Met met the Met + Cys requirements according to the NRC recommendations (National Research Council (NRC) 1994) and were about 15% below the breeder's recommendations, and those supplemented with 0.40% Met exceeded recommendations of NRC by 35% and the breeder's recommendations by 15%-20%. For the analysed dietary Met and Met + Cys concentrations in the experimental diets, see Zeitz et al. (2018) . Body weight (individually) and feed consumption (per cage) were determined at days 10, 21 and 35.
| Sample collection and laboratory analyses
At slaughter (days 10, 21 and 35), weights of carcass and breast muscle were recorded from each 6 birds per experimental group at days 10 and 21 and from 15 birds per experimental group at day 35.
Samples from liver and breast muscle were collected from six birds per experimental group at all time points, snap-frozen in liquid nitrogen and stored at −80°C.
RNA isolation, cDNA synthesis and quantitative PCR (qPCR) were performed according to Zeitz, Most, and Eder (2016) . In brief, total RNA was isolated from the tissue using Trizol reagent (Invitrogen) according to the manufacturer's protocol and preserved at −80°C until use. The cDNA was synthesized after RNA extraction from 1.2 µg of total RNA using random hexamer primers, and cDNA was stored at −20°C. The qPCR was performed using 2 µl of 1:2 diluted cDNA combined with 8 µl of a mixture composed of 5 µl KAPA SYBR FAST qPCR Universal Mastermix (Peqlab, Erlangen, Germany), 0.2 µl each of 10 µM forward and reverse primers and 2.6 µl DNase/RNase free water in 0.1 ml tubes (Ltf Labortechnik, Wasserburg, Germany).
The characteristics of the gene-specific primer pairs, obtained from Eurofins Genomics (Ebersberg, Germany), are listed in Table 2 . Using the Microsoft Excel-based application GeNorm, the GeNorm normalization factor was calculated as the geometric mean of expression data (relative quantities) of the three most stable (GAPDH, SDHA, YWHAZ) out of four to five tested potential reference genes (ACTB, GAPDH, SDHA, YWHAZ, RPL32). M and V values were below the threshold level of 1.5 and 0.15 respectively (Vandesompele et al., 2002) . In liver, the M value was 0.49, and the V3/V4 value was 0.11.
In muscle, calculation was done separately for each broiler age due to a significant effect of age. M values were 0.43, 0.61 and 0.68 for starter, grower and finisher data sets, and V3/V4 values were 0.12, 0.14 and 0.13 respectively. The normalized expression values data set was corrected for outliers. Means and SD were calculated from normalized expression data for samples of the same experimental group. The mean of the control group was set to 1, and the means and SD of the treatment groups were scaled proportionally.
For western blotting, approximately 150 mg of frozen muscle tissue was homogenized in RIPA buffer (50 mM Tris, 150 mM NaCl, 10% glycerol, 0.1% SDS, 10% Triton X-100, 1 mM EDTA, 0.5% deoxycholate, pH 7.5), including a protease inhibitor solution (1:200; SigmaAldrich, Steinheim, Germany) and a phosphatase inhibitor solution (1 mM sodium orthovanadate, 5 mM NaF; Sigma-Aldrich) at 15 Hz for 5 min in the Tissue Lyzer (Qiagen) and immediately put on ice afterwards. The samples were centrifuged (16,200 g, 4°C, 15 min) , and the supernatant was stored at −20°C. In the homogenates, protein concentrations were determined, with BSA as standard, with the TA B L E 1 Ingredient composition and nutrient concentrations of the basal diets fed during the starter (day 1-10), grower (day 11-21) 
| Statistical analysis
The data sets were tested for normal distribution of the residuals and were subjected to a three-way ANOVA considering Met source, dietary Met concentration, experimental run and their interactions as fixed factors with Minitab (Release 13). The Metgroup was included in the ANOVA as "DLM group without supplementation" and as "DL-HMTBA group without supplementation".
Experimental run and interactions between experimental run and
Met source or concentration were not significant, and the respec- 
| RE SULTS
| Growth performance and carcass characteristics
Growth performance and carcass characteristics of the broilers are described in Zeitz et al. (2018) . In brief, final body weights and carcass weights, daily gains and feed intake were significantly lower and the feed:gain ratio was significantly higher in the Met- (Table 3 ). In addition, hepatic IGF1 expression was lower in the Met-group compared to birds fed Met-supplemented diets at day 10 and tended to be lower in the Met-group and 0.10% Met-supplemented group compared to birds fed 0.40% Met at day 35 (Table 3 ). The mRNA abundance of IGFBP2 was lower in the Met-group than in birds fed 0.10% Met at day 10, but was unaffected at days 21 and 35 (Table 3 ).
In the breast muscle, feeding diets with Met + Cys concentrations below recommendations slightly affected expression of genes involved in anabolic pathways, but their expression was unaffected by dietary Met source (Table 4 ). The mRNA abundance of GHR was lower (day 10) or in tendency lower (day 21) in the Met-group compared to birds fed diets supplemented with 0.40% Met (Table 4) .
Similarly, gene expression of IGF1 was lower in the Met-group compared to birds whose diets were supplemented with 0.10% Met (day 10) and tended to be lower compared to birds fed diets supplemented with 0.40% Met (day 21) (Table 4) . Additionally, the expression of MYOD1, involved in muscle differentiation, was higher in birds fed diets with 0.40% Met-supplemented compared to birds fed diets with 0.10% Met (day 10) or with Met-diets (day 21). The expression of MYOG, also involved in muscle growth, was higher in 0.10% Met-supplemented groups compared to the Met-group at day 35, which was the only investigated gene affected at this time point (Table 4 ). The mRNA abundance of the other genes involved in the somatotropic axis (IGF1R, IGFBP2), of all three investigated genes involved in protein synthesis (mTOR, S6K1, 4EBP1) and of the muscle growth-related gene MYF5 remained unaffected at all time points (Table 4) . Concomitantly, in the muscle, the ratios of phosphorylated to total antibody, that is, the relative phosphorylation levels of mTOR and rpS6 which are involved in the mTOR signalling pathway which stimulates translation initiation after phosphorylation of these proteins, did not differ among groups at all three broiler ages (Figure 2a 
| Effects of dietary Met supplementation on molecular pathways of protein degradation and inhibition of protein synthesis
Molecular pathways of protein degradation and inhibition of protein synthesis in the breast muscle of growing broilers were not TA B L E 3 Hepatic mRNA abundance of genes involved in the somatotropic axis in broilers fed either a basal diet (Met-group) or a diet supplemented with 0.10% or 0.40% of DLM or DL-HMTBA at days 10, 21 and 35 (mean ± SD) Table 2. affected by Met source, but were slightly altered by Met concentration (Table 5 ). Gene expression of the FOXO1 transcription factor and the expression of one of its targets, FBOX32, a muscle-specific ubiquitin ligase also called atrogin-1, were similar among groups (Table 5) . Likewise, the relative phosphorylation levels of FOXO1, which stimulates protein degradation in the dephosphorylated TA B L E 4 mRNA abundance of genes involved in the somatotropic axis (GHR, IGF1, IGF1R, IFGBP2), the mTOR signalling pathway (MTOR, S6K1, 4EBP1), and of muscle growth-related genes (MYOD1, MYF5, MYOG) in the breast muscle of broilers fed either a control diet (Control) or a diet supplemented with 0.10% or 0.40% of DLM or DL-HMTBA at days 10, 21 and 35 (mean ± SD) However, at day 10, the gene expression of TRIM63, also called MURF1, another muscle-specific ubiquitin ligase, was lower in birds which received Met supplementation of 0.40% compared to the Met-group and the groups fed the diets supplemented with 0.10% Met (Table 5) . Similarly, at day 21, the expression of MURF1 was lower in birds fed Met-supplemented diets compared to those in the Met-group, whereas expression at day 35 was not affected (Table 5 ).
Gene expression of autophagy-related genes was unaffected by Met concentration in 11-and 21-day-old birds (Table 5) . At day 35, expression of ATG9A was unaffected as well, whereas that of ATG5 was lower when 0.40% Met were supplemented compared to the Met-groups and birds fed 0.10% Met in their diets, and that of BECN1 was lower when 0.10% and 0.40% Met were supplemented compared to the Met-group (Table 5) . Expression of SQSTM1, involved in the GCN2/eIF2a pathway of protein synthesis inhibition, was unaffected at days 10 and 21, but downregulated by supplementing Met compared to the Met-group at day 35 (Table 5 ). The relative phosphorylation of eIF2a, however, was unaffected at all broilers ages (Figure 3g-i) .
| D ISCUSS I ON
We showed that supplementation of Met affected breast muscle weights, and thus muscle growth, compared to diets which contained Met + Cys concentrations which were insufficient for maximal growth. This can mainly be explained by the role of Met as a proteinogenic amino acid and is consistent with previous publications (Esteve-Garcia & Llauradó, 1997; Lemme Hoehler, Brennan, & Mannion, 2002) . Interestingly, DL-Met seemed better able to support breast muscle growth, as breast muscle proportional to carcass weight was higher at 0.10% supplementation, that is, at marginal dietary Met concentrations, when DL-Met was supplemented compared to when DL-HMTBA was supplemented. This is in line with studies reporting that, in contrast to DL-Met, DL-HMTBA does not stimulate mTOR signalling in myoblasts (Métayer-Coustard et al., 2010) . Therefore, we also expected to observe significant effects of Met dosage and source of protein synthesis and degradation on the molecular level when investigating mTOR signalling to stimulate protein synthesis, UPP-and autophagy-related protein degradation, the GCN2/eIF2a pathway which inhibits mTOR (Métayer et al., 2008) and stimulates autophagy (He & Klionsky, 2009) , and the myostatin-Smad2/3 pathway related to muscle growth and differentiation.
However, our results showed no effect of Met source on these pathways. Some effects of Met concentration were observed as suboptimum Met concentrations in the basal diet fed Met-group reduced IGF1 signalling (GHR, IGF1) and increased protein degradation on the molecular level via UPP (MURF1) and autophagy (ATG5, BECN1/ ATG6), mainly when compared to the groups fed diets with a surplus of Met (0.40% groups). IGF1 signalling is known to be connected to growth in broilers; for example, one study showed a correlation between bird weight and serum IGF concentrations as well as breast muscle IGF1 expression (Xiao et al., 2017) . In contrast to our expectations, the Met source neither affected anabolic nor catabolic pathways in the muscle on the molecular level. Our data also indicate that protein synthesis on the molecular level was not affected by Met dosage at any investigated broiler age.
Neither gene expression nor phosphorylation and thus activation state of the proteins involved in the mTOR pathway (mTOR, S6K1, rpS6) and the GCN2/eIF2a pathway (eIF2a), which are both primarily regulated by phosphorylation (He & Klionsky, 2009; Vary & Lynch, 2007) , were affected. This was also corroborated by measurement of relative phosphorylation of Akt which is upstream of mTOR (Glass, 2010) , which was also unaffected by Met dosage. The finding that the GCN2/eIF2a pathway was not affected by Met coincides with data from others (Métayer-Coustard et al., 2010; Wanders et al., 2016) . The finding that molecular pathways of protein synthesis were unaffected by Met supplementation level or source was, however, unexpected, as it has been repeatedly reported that both Leu and Met positively regulate protein synthesis, namely through mTOR signalling (Atherton et al., 2010; Fox et al., 1998; Métayer-Coustard et al., 2010; Tesseraud et al., 2003) . Mechanistically, the effect of Met on mTOR signalling is explained by Met being sensed by members of the taste receptor type 1 (T1R) family, of which the T1R1/T1R3 complex is a direct sensor of AA availability, which then leads to phospholipase C β2 stimulation and in turn stimulates mitogen-activated protein kinases (MAPK/ERK1/2) and S6K1 (Kokabu, Lowery, Toyono, Sato, & Yoda, 2017; Zhou, Ren, Song, Peng, & Wei, 2016) . In addition, the Met metabolite S-adenosylmethionine (SAM) complexes with SAM sensor upstream of mTORC1 (SAMTOR) and by this reduces the inhibition of mTOR signalling (Gu et al., 2017) .
However, in the present study, we did not detect an effect of Met source or supplementation level on mTOR signalling. It seems that reduced muscle growth in the birds fed diets with suboptimum Met F I G U R E 2 Relative phosphorylation level (fold of Met-group) of mammalian target of rapamycin (mTOR) (a-c), 70 kDa ribosomal protein S6 kinase 1 (S6K1) (d-f) and ribosomal protein S6 (rpS6) (g-i) in the breast muscle of broilers at day 10 (a,d,g), day 21 (b,e,h) and day 35 (c,f,i) which were fed either a basal diet (Met-group) or a diet supplemented with 0.10% or 0.40% of DLM or DL-HMTBA (mean ± SD; n = 6). There were no significant (p < 0.05) differences between experimental groups concentrations in our study was mainly due to lack of the essential AA Met for inclusion in skeletal muscle protein. However, it has also previously been shown that Met supplementation may affect muscle cell differentiation and decrease myostatin expression to support muscle growth (LIU, Zong, Zhang, & Cao, 2010; Wen, Chen, et al., 2014a) . Therefore, we have also investigated gene expression of three transcription factors related to muscle growth and differentiation, of which MYOD1 and MYF5 are required for myogenic determination, and MYOG is involved in myotube differentiation (Sabourin & Rudnicki, 2000) . Changes in the expression of MYOD1
and MYOG at some investigated time points in the present study indicate that satellite cell activation and thus myogenic determination, as well as muscle cell differentiation, may be affected by dietary Met supplementation level.
Akt has a dual role in protein turnover, by both activating the mTOR pathway and inhibiting FOXO induced protein degradation (Yu & Cui, 2016) . Therefore, we investigated relative phosphorylation of both Akt and FOXO; however, neither was affected by Met source or concentration. Together with the unchanged gene expression of atrogin-1, this could indicate that protein degradation F I G U R E 3 Relative phosphorylation level (fold of Met-group) of protein kinase B (Akt) (a-c), forkhead box protein (FOXO) (d-f) and eukaryotic translation initiation factor 2A (eIF2a) (g-i) in the breast muscle of broilers at day 10 (a,d,g), day 21 (b,e,h) and day 35 (c,f,i) which were fed either a basal diet (Met-group) or a diet supplemented with 0.10% or 0.40% of DLM or DL-HMTBA (mean ± SD; n = 6). There were no significant (p < 0.05) differences between experimental groups TA B L E 5 mRNA abundance of genes involved in the GCN2/eIF2a pathway (SQSTM1), the UPP (FOXO1, MURF1, FBXO32 For abbreviations see Table 2 . Means with different superscripts within rows differ significantly in the post hoc test (p < 0.05). When no significant letters are allocated although p < 0.05, significant differences in the post hoc test were not detected.
via the UPP was not influenced in the present study. However, Met supplementation provoked downregulation of MURF1 in the young broilers as compared to the Met-group. It should be noted that the expression of FBXO32 and MURF1 is not only regulated by the IGF1/Akt/FOXO pathway, but also affected by the p38 mitogen-activated protein kinase (MAPK), and the nuclear factor-kappa B (NF-κB) pathways (Rom & Reznick, 2016) , the latter being linked to the IGF1 signalling pathway (Salminen & Kaarniranta, 2010) .
Interestingly, the Met metabolite SAM has been shown to inhibit IκB kinase (IKK) phosphorylation which is necessary for activation of NF-κB (García-Román et al., 2008) which will again increase skeletal muscle catabolism due to activation of MURF1, but not of atrogin-1 (Rom & Reznick, 2016) . Because it is probable that levels of SAM were lower in birds of the Met-group, and because expression of MURF1 was increased while FOXO1 and FBXO32 levels were unchanged, one possible explanation for these findings is activation of the IKK-β/NF-κB/MuRF-1 pathway in the Met-group. Similarly, NF-κB activation has been shown to induce muscle wasting in mice and to increase expression of MURF1, but not that of atrogin-1 (Cai et al., 2004) . In addition, a slight induction of oxidative stress has been shown in the Met-group (Zeitz et al., 2018) , which may not only induce the master regulator of the antioxidant response, nuclear factor (erythroid-derived 2)-like 2 (Nrf2), (Gorrini, Harris, & Mak, 2013 ), but also NF-κB signalling (Morgan & Liu, 2011) . Additionally, on the molecular level, Met deprivation has been reported to induce autophagy (Liu et al., 2015; Sutter et al., 2013) , which has been connected to reduced levels of the Met/Cys metabolite glutathione (GSH) compromising cellular reactive oxygen species (ROS) detoxification (Liu et al., 2015) . Likewise, higher expression of some autophagy-related genes in the Met-group in the present study indicate that at least a slight activation of autophagy-lysosomal protein degradation was detected at day 35 in broilers fed Met-diets compared to broilers fed diets adequate in Met. Although this effect of Met was only minor in the present study, we principally confirm what has been described by others: adequate Met supplementation may reduce protein degradation in broiler muscle (Del Vesco et al., 2015; Wen, Wu, et al., 2014b) .
| CON CLUS ION
In conclusion, the study results imply that compared to diets which contain Met + Cys concentrations below requirements, feeding broilers diets with adequate Met supplementation can increase muscle growth, with very little effect on protein synthesis via the IGF1-PI3K-Akt-mTOR pathway. However, it seems that protein degradation may be inhibited by adequate dietary Met supplementation which could be mediated by inhibition of NF-κB activation and its subsequent induction of protein degradation pathways.
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